Meril was born with the aim of improving the quality of human life through innovative and advanced healthcare solutions. As a medical device manufacturer, we exist to improve the inventiveness in healthcare so that people’s lives are enriched. We continually seek excellence in providing answers to some of surgical’s toughest questions.
Founded in 2006, Meril is an India-based, global medical device company that is dedicated to the innovation, design and development of novel, clinically relevant and state-of-the-art devices. Our fundamental aim is to champion the alleviation of human suffering and improve quality of life.
To enable this, we are committed to R&D and innovation in manufacturing medical technology.
Our inclination towards research and development is reflected in our diverse offerings. We collaborate with physicians and global innovators to identify unmet clinical needs and develop revolutionary therapies. We encourage research and academic collaborations and remain available to interact on exciting opportunities.
Headquartered in India with a manpower of more than 4000, Meril currently conducts business in more than 100 countries. We have 100% subsidiaries in India, USA, Germany, Brazil, Russia, South Africa, Bangladesh and Turkey. We have set up operations in China and Japan too.
Meril demonstrated excellent business performance due its presence in over 100 countries globally, and a number of new, unique product launches. In FY 2018, Meril launched its Structural heart portfolio with Myval Transcatheter heart valve. Recently, Myval also received the CE mark certification approval. The company has made this technology available in European and other countries, which is a milestone achievement in Meril’s history.
Meril has its own in-house Innovation lab and training facility equipped to address customer needs and also support skill/education training. Meril’s training academy is one of the largest dedicated med-tech setups in Asia Pacific; it offers customized training programs for doctors. The company has provided training to more than 10,000 Healthcare professionals in the last few years academy in Vapi, Gujarat. Meril designed Myval and MeRes100, two such innovative technologies for treatment of vascular and valvular disease therapy areas to serve critical patients’ needs. Meril Academy organizes various training programs for the latest TAVR therapy and has trained over 400 Interventional cardiologists in a shot span of 6 months with both in-house and in-lab modules